BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD
Clinical studies have supported the use of naltrexone in the treatment of MUD, as well as the combination of naltrexone with bupropion to significantly reduce the use of methamphetamines.
- Clinical studies have supported the use of naltrexone in the treatment of MUD, as well as the combination of naltrexone with bupropion to significantly reduce the use of methamphetamines.
- MUD represents a significant public health concern, with devastating consequences for individuals, families, and communities across the country.
- Despite the growing prevalence of MUD, effective treatment options remain limited, underscoring the urgent need for innovative approaches to address this complex and challenging condition.
- Currently, there are no approved medications for MUD, and populations at risk of methamphetamine-involved overdose deaths are diversifying.